Image For Activity Cover
SSO Virtual Tumor Board: GI - August 2022
ctDNA - Application for Different GI Diseases
Activity Overview

In this tumor board, the participants will be able to:

  • Define molecular residual disease (MRD) in mCRC patients undergoing metastasectomy
  • Discuss pattern of failure after resection of mCRC metastases
  • Discuss the role of imagining, CEA, and cDNA in the detection of recurrence after CRC resection
June S. Peng, MD, Assistant Professor of Surgery, Penn State Cancer Institute and
Jan Franko, MD, PhD, FACS, FSSO, Surgical Oncologist, MercyOne Des Moines Surgical Group 

Fadi Dahdaleh, MD, Surgical Oncologist, Edward-Elmhurst Healthcare
Kanika Nair, MD, Medical Oncologist, Cleveland Clinic
Colette R. Pameijer, MD, Professor of Surgery and Chief, Penn State Cancer Institute
Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Powered By